PETER BARTON HUTT
CIK 1171527 · last filed 2023-03-06
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Loading insider history…
Disclosed Exposure
$12.23M
Companies
14
Total Filings
77
Lifetime Open-Market Net
-$7.95M
Holdings By Company
Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| CONCERT PHARMACEUTICALS, INC. (CNCE) Delisted | Director | 0 | $8.37 | $0 | -$275.1K | 14 | 2023-03-06 |
| IMMUNOMEDICS INC (IMMU) Delisted | Director | 0 | — | — | $0 | 5 | 2020-10-23 |
| MRNA | Director | 203,924 | $59.49 | $12.13M | -$5.80M | 3 | 2019-11-22 |
| Salarius Pharmaceuticals, Inc. (FLKS) Delisted | Director | 467 | — | — | $0 | 5 | 2018-07-26 |
| Cartesian Therapeutics, Inc. (SELB) Delisted | Director | — | $0.88 | — | $0 | 2 | 2018-06-19 |
| XOMA | Director | — | $40.17 | — | $0 | 9 | 2017-05-22 |
| DNIB UNWIND, INC. (BIND) Delisted | Director | — | — | — | $0 | 2 | 2016-06-22 |
| MCRB | Director | — | $5.11 | — | $0 | 2 | 2016-06-17 |
| MOMENTA PHARMACEUTICALS INC (MNTA) Delisted | Director | 6,725 | — | — | -$1.88M | 10 | 2014-09-15 |
| ISTA PHARMACEUTICALS INC (ISTA) Delisted | Director | 4,932 | — | — | $0 | 5 | 2011-12-07 |
| Celera CORP (CRA) Delisted | Director | — | — | — | $0 | 3 | 2010-05-27 |
| INGN | Director | 15,419 | $6.40 | $98.7K | $0 | 3 | 2008-06-13 |
| MMRGlobal, Inc. (FVRL) Delisted | Director | — | — | — | $0 | 1 | 2007-06-21 |
| CV THERAPEUTICS INC (CVTX) Delisted | Director | — | — | — | $0 | 1 | 2007-06-04 |
Recent Filings · Page 2 of 8
77 filingsInsider activity across all companies, newest first. Form 4 rows are post-trade confirmations (buys, sells, grants, exercises). Notice (144) rows are pre-trade notices of intent to sell restricted or control stock under Rule 144 — they may not all execute. Compare adjacent dates to see which notices became actual sales.
| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2019-08-12 | CONCERT PHARMACEUTICALS, INC. (CNCE) Delisted | Mixed | — | -$20.9K | EDGAR |
| 2019-06-28 | MRNA | Grant (A) | — | $0 | EDGAR |
| 2019-06-17 | CONCERT PHARMACEUTICALS, INC. (CNCE) Delisted | Grant (A) | — | $0 | EDGAR |
| 2019-06-11 | IMMUNOMEDICS INC (IMMU) Delisted | Grant (A) | +9,667 | $0 | EDGAR |
| 2018-09-18 | IMMUNOMEDICS INC (IMMU) Delisted | Grant (A) | +3,849 | $0 | EDGAR |
| 2018-07-26 | Salarius Pharmaceuticals, Inc. (FLKS) Delisted | Grant (A) | — | $0 | EDGAR |
| 2018-06-19 | Cartesian Therapeutics, Inc. (SELB) Delisted | Grant (A) | — | $0 | EDGAR |
| 2018-06-18 | CONCERT PHARMACEUTICALS, INC. (CNCE) Delisted | Grant (A) | — | $0 | EDGAR |
| 2017-07-27 | Salarius Pharmaceuticals, Inc. (FLKS) Delisted | Grant (A) | — | $0 | EDGAR |
| 2017-07-06 | IMMUNOMEDICS INC (IMMU) Delisted | Grant (A) | — | $0 | EDGAR |
Form 4 codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.